about
A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depressionProximal protection with the Gore PAES can reduce DWI lesion size in high-grade stenosis during carotid stenting.Subacute reversible toxic encephalopathy related to treatment with capecitabine: a case report with literature review and discussion of pathophysiology.Predicting primary progressive aphasias with support vector machine approaches in structural MRI data.Pattern of serum autoantibodies allows accurate distinction between a tumor and pathologies of the same organ.Bringing the hospital to the patient: first treatment of stroke patients at the emergency site.Dosage Calculation for Intravenous Thrombolysis of Ischemic Stroke: To Weigh or to Estimate?Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD.Standard operating procedures improve acute neurologic care in a sub-Saharan African setting.Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons.The PRIPS study: screening battery for subjects at risk for Parkinson's disease.Moderately elevated plant sterol levels are associated with reduced cardiovascular risk--the LASA study.Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays.Intracellular APP Domain Regulates Serine-Palmitoyl-CoA Transferase Expression and Is Affected in Alzheimer's Disease.Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteriesDeficiency of Neuronal p38α MAPK Attenuates Amyloid Pathology in Alzheimer Disease Mouse and Cell Models through Facilitating Lysosomal Degradation of BACE1.Inflammatory cytokines in CSF in bacterial meningitis: association with altered blood flow velocities in basal cerebral arteries.Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI Study.Spingolipids in Multiple Sclerosis.Endovascular stroke treatment today.Ischemic stroke in children: new aspects of treatment.Sphingolipids in neuroinflammation.Molecular links between endothelial dysfunction and neurodegeneration in Alzheimer's disease.Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias.[Stroke]Facial emotion recognition in Parkinson's disease: Association with age and olfaction.Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges.Prehospital Imaging-Based Triage of Head Trauma with a Mobile Stroke Unit: First Evidence and Literature Review.Invasion of human epithelial cells by Pseudomonas aeruginosa involves src-like tyrosine kinases p60Src and p59Fyn.Simple measurement of aneurysm residual after treatment: the SMART scale for evaluation of intracranial aneurysms treated with flow diverters.Comparison of Antiepileptic Approaches in Treatment of Benzodiazepine Nonresponsive Status Epilepticus.Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species.Retrospective Consent to Hemicraniectomy after Malignant Stroke among the Elderly, Despite Impaired Functional Outcome.Neuropsychological impairment in prodromal Parkinson's disease.High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs.Abnormal galactosylation of immunoglobulin G in cerebrospinal fluid of multiple sclerosis patients.C-reactive protein and the acute phase reaction in geriatric patients.Is prehospital treatment of acute stroke too expensive? An economic evaluation based on the first trial.Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination
P50
Q26866012-05D09AB1-416E-4846-920D-C5FE7C78D221Q30757815-5255439A-7D1F-4906-B713-92F6C28B006BQ30778472-F9DD96E4-D94C-415B-B67E-0C1A3C976AB1Q31164984-90807551-0A47-4FA4-B1B9-5B3AF9630ED1Q33357293-DCCE08B2-87BC-4C06-8D5D-E2496578725EQ33741926-6E51E7D4-D456-45CC-BB99-FE9652985CF3Q33801602-D95C2147-E8E7-4C57-941B-6CF783EBDAA2Q33863540-479F6354-4605-4E00-8E0C-0E3801B5AC34Q33885261-408EF3B4-D92B-46DD-A7D1-963492FA7142Q33957588-B43F44D9-F9AD-49A3-BEFD-D3C34A4E1CA7Q34361343-5120C8CA-6152-4D5A-9102-98A84B2760CDQ34586115-75BD11EC-1145-4940-BBC7-B4679146BAF5Q34618619-B14F23E2-776D-4123-B9B9-9D6CC82298F2Q35030310-AD1F0E3B-B946-4190-A909-EF622A51C595Q35461644-81EE4E11-72B8-4450-A706-738A8C8B2838Q36518225-294CCDB2-BD13-4868-B7E5-3DAFDFADEDABQ36894296-B02F26EB-F8CE-4D56-B87F-DB06A57EBFF2Q37683134-78773BC7-6FD2-4A94-8B7B-B5079162EB98Q37760687-0B230BCD-03FD-4A08-A571-98FAC3535185Q37828312-BE526525-4D61-4782-8E75-784ADFB554A1Q37876987-6818FA20-190A-42F9-8B4D-EC6601150D06Q38096854-64D02FD9-FB30-4309-829F-B78F98EC7E69Q38164018-EEC5CEE6-AAE7-4C43-8C49-E9D8B4336B53Q38381072-8975D587-968B-4F28-AAA9-D493AE17591BQ38451382-E035677D-9BAF-4E90-8E52-E1203AFB36D0Q38668372-C21FE036-A3F6-4A8E-A24D-4B8E7F6573C5Q38754285-24FE57A0-3965-41F3-8987-D071F7180A7AQ38829741-396635B1-7C2D-495B-9B36-EFFCF01F0391Q39517821-216B4235-8B59-4918-BA0A-13470202623EQ39696959-20F1A3B8-D89C-4200-BC70-9F90852BEAC2Q40027459-796A017C-E9BB-4DF8-A876-C291A75AC990Q40056685-347F0A93-42AD-475B-AF34-D59E5493B5E5Q40196823-D9CD81EC-150A-4E54-AB17-7E048690B46FQ40384119-8786ECD5-269D-480C-89C6-70930447CD4EQ40463741-B12F75E1-993C-4229-B5F4-475AFFA48C14Q40541341-26FFF5B6-8800-4245-ABF0-3FE21EAE464AQ40906486-3742AB9B-ACF9-4CEB-B798-C56E0ADADAB2Q41018619-3FAC5F86-8EBD-4195-84F8-550B930AA136Q41659858-22C76D64-3863-44AD-AE93-F375B2FF4CF4Q42221029-261DEE64-25FF-405E-856C-E5B581B98242
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Klaus Fassbender
@ast
Klaus Fassbender
@en
Klaus Fassbender
@es
Klaus Fassbender
@nl
Klaus Fassbender
@sl
type
label
Klaus Fassbender
@ast
Klaus Fassbender
@en
Klaus Fassbender
@es
Klaus Fassbender
@nl
Klaus Fassbender
@sl
altLabel
Klaus Faßbender
@en
prefLabel
Klaus Fassbender
@ast
Klaus Fassbender
@en
Klaus Fassbender
@es
Klaus Fassbender
@nl
Klaus Fassbender
@sl
P106
P21
P31
P4012
P496
0000-0003-3596-868X